National Organizations Urge Senate Action to Prevent Shortages of Critical Drugs in Response to the Coronavirus Outbreak

Premier and 13 other national organizations called on the Senate Health, Education, Labor and Pensions Committee to expeditiously advance S. 2723 – The Mitigating Emergency Drug Shortages (MEDS) Act. As the United States takes steps in response to the outbreak of COVID-19, concerns with the integrity of the drug supply chain and the potential impact on downstream drug shortages have surfaced. Premier supports the MEDS Act as a holistic and sustainable approach to eliminating drugs shortages and addressing vulnerabilities in the drug supply chain.